- Filed
- May 10, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 36.12M sh |
| Short Term Investments | Q1 2024 · Mar 31, 2024 | $302.5M |
| Short Term Investments | Q1 2024 · Dec 31, 2023 | $280.74M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $146.65M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $251.18M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $35.56M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $40.01M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $88.57M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $92.36M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $480.39M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $550.65M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $629.77M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $667.59M |
| Revenue | Q1 2024 · Mar 31, 2024 | $0 |
| Revenue | Q1 2024 · Mar 31, 2023 | $12.6M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 35.72M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $119K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$26.56M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $652.26M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $663.33M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.44 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.44 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $11.93M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $25.6M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$15.55M |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$24.93M |